• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒主蛋白酶的失活

On Inactivation of the Coronavirus Main Protease.

机构信息

Department of Chemistry, Illinois Institute of Technology, Chicago, Illinois 60616, United States.

出版信息

J Chem Inf Model. 2024 Mar 11;64(5):1644-1656. doi: 10.1021/acs.jcim.3c01518. Epub 2024 Feb 29.

DOI:10.1021/acs.jcim.3c01518
PMID:38423522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10936523/
Abstract

A deeper understanding of the inactive conformations of the coronavirus main protease (MPro) could inform the design of allosteric drugs. Based on extensive molecular dynamics simulations, we built a Markov State Model to investigate structural changes that can inactivate the SARS-CoV-2 MPro. In a subset of structures, one subunit of the homodimer assumes an inactive conformation that resembles an inactive crystal structure. However, contradicting the widely held half-of-sites activity hypothesis, the most populated enzyme structures have two active subunits. We then used transition path theory (TPT) and the Jensen-Shannon Divergence (JSD) to pinpoint residues involved in the inactivation process. A π stack between Phe140 and His163 is a key feature that can distinguish active and inactive conformations of MPro. Each subunit has unique inactive conformations stabilized by π stacking interactions involving residues Phe140, Tyr118, His163, and His172, a hydrogen bonding network centered around His163 and His172, and a modified network of interactions in the dimer interface. The importance of these residues in maintaining an active structure explains the sensitivity of enzymatic activity to site-directed mutagenesis.

摘要

深入了解冠状病毒主蛋白酶(MPro)的无活性构象,可以为别构药物的设计提供信息。基于广泛的分子动力学模拟,我们构建了一个马尔可夫状态模型来研究可以使 SARS-CoV-2 MPro 失活的结构变化。在一组结构中,同源二聚体的一个亚基采用类似于无活性晶体结构的无活性构象。然而,与广泛持有的半位点活性假说相反,最常见的酶结构具有两个活性亚基。然后,我们使用转移路径理论(TPT)和 Jensen-Shannon 散度(JSD)来确定参与失活过程的残基。Phe140 和 His163 之间的π堆积是一个关键特征,可以区分 MPro 的活性和无活性构象。每个亚基都有独特的无活性构象,由涉及残基 Phe140、Tyr118、His163 和 His172 的π堆积相互作用、以 His163 和 His172 为中心的氢键网络以及二聚体界面中相互作用的修饰网络稳定。这些残基在维持活性结构中的重要性解释了酶活性对定点诱变的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/82521b770825/ci3c01518_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/7d181321b32a/ci3c01518_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/6b94a692ec05/ci3c01518_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/cc68783d1567/ci3c01518_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/71544c1f0eb4/ci3c01518_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/6559e28654bc/ci3c01518_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/3c243172e38f/ci3c01518_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/602b4bed1c57/ci3c01518_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/bd5f58710941/ci3c01518_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/82521b770825/ci3c01518_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/7d181321b32a/ci3c01518_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/6b94a692ec05/ci3c01518_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/cc68783d1567/ci3c01518_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/71544c1f0eb4/ci3c01518_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/6559e28654bc/ci3c01518_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/3c243172e38f/ci3c01518_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/602b4bed1c57/ci3c01518_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/bd5f58710941/ci3c01518_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4d1/10936523/82521b770825/ci3c01518_0009.jpg

相似文献

1
On Inactivation of the Coronavirus Main Protease.冠状病毒主蛋白酶的失活
J Chem Inf Model. 2024 Mar 11;64(5):1644-1656. doi: 10.1021/acs.jcim.3c01518. Epub 2024 Feb 29.
2
Insight into crystal structures and identification of potential styrylthieno[2,3-]pyridine-2-carboxamidederivatives against COVID-19 Mpro through structure-guided modeling and simulation approach.通过结构导向建模和模拟方法深入了解晶体结构并鉴定针对 COVID-19 Mpro 的潜在苯乙烯噻吩并[2,3-]吡啶-2-甲酰胺衍生物。
J Biomol Struct Dyn. 2024 May;42(8):4325-4343. doi: 10.1080/07391102.2023.2220799. Epub 2023 Jun 15.
3
Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases.二聚化和N3结合对严重急性呼吸综合征冠状病毒(SARS-CoV)和新型冠状病毒(SARS-CoV-2)主要蛋白酶分子动力学的影响
J Biomol Struct Dyn. 2022 Sep;40(14):6243-6254. doi: 10.1080/07391102.2021.1880481. Epub 2021 Feb 2.
4
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.GC376 和奈玛特韦稳定 SARS-CoV-2 主蛋白酶二聚体状态。
Int J Mol Sci. 2023 Mar 23;24(7):6062. doi: 10.3390/ijms24076062.
5
Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.喹啉衍生物作为抗SARS-CoV-2蛋白酶抑制剂的设计、合成及分子动力学模拟研究
J Biomol Struct Dyn. 2022;40(21):10519-10542. doi: 10.1080/07391102.2021.1946716. Epub 2021 Jul 12.
6
In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease.伊维菌素和奈玛特韦抑制剂与 SARS-CoV-2 主蛋白酶相互作用的计算机比较分析。
Biomolecules. 2024 Jun 25;14(7):755. doi: 10.3390/biom14070755.
7
Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.通过计算筛选和体外蛋白酶测定研究抗 SARS-CoV-2 主蛋白酶的抗病毒肽。
J Pept Sci. 2024 Apr;30(4):e3553. doi: 10.1002/psc.3553. Epub 2023 Nov 29.
8
Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.纳库巴因针对 SARS-CoV-2 蛋白酶的再利用的分子结合机制和药理学比较分析。
J Proteome Res. 2020 Nov 6;19(11):4678-4689. doi: 10.1021/acs.jproteome.0c00367. Epub 2020 Sep 4.
9
An analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease.分析高浓度氯化钠中布洛芬对体 SARS-CoV-2 主蛋白酶的作用。
J Biomol Struct Dyn. 2022 Aug;40(12):5653-5664. doi: 10.1080/07391102.2021.1872420. Epub 2021 Jan 18.
10
Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme.深入了解SARS主要蛋白酶的活性:酶的二聚体和单体形式的分子动力学研究
Proteins. 2007 Feb 1;66(2):467-79. doi: 10.1002/prot.21160.

引用本文的文献

1
Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding.包含二聚化和配体结合的冠状病毒主要蛋白酶的酶动力学模型。
bioRxiv. 2025 Jan 2:2025.01.01.631001. doi: 10.1101/2025.01.01.631001.

本文引用的文献

1
pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity.阐明 SARS-CoV-2 3-胰凝乳蛋白酶样蛋白酶(3CLpro)的 pH 曲线有助于揭示其催化机制和对活性至关重要的组氨酸残基。
J Biol Chem. 2023 Feb;299(2):102790. doi: 10.1016/j.jbc.2022.102790. Epub 2022 Dec 9.
2
Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.从美国食品和药物管理局批准的药物库中发现并研究了溴托铵的作用机制,其对人类冠状病毒的主要蛋白酶具有强大且广谱的抑制活性。
Bioorg Chem. 2023 Jan;130:106264. doi: 10.1016/j.bioorg.2022.106264. Epub 2022 Nov 9.
3
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS-CoV-2 Infection and COVID-19.
最近用于治疗 SARS-CoV-2 感染和 COVID-19 的药物开发和药物化学方法。
ChemMedChem. 2022 Nov 18;17(22):e202200440. doi: 10.1002/cmdc.202200440. Epub 2022 Oct 13.
4
Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain.单体 SARS-CoV-2 主要蛋白酶催化结构域与 GC373 和奈玛特韦结合后的自动加工和氧阴离子环重组。
Commun Biol. 2022 Sep 16;5(1):976. doi: 10.1038/s42003-022-03910-y.
5
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.定义 SARS-CoV-2 主蛋白酶的底物信封,以预测和避免耐药性。
Nat Commun. 2022 Jun 21;13(1):3556. doi: 10.1038/s41467-022-31210-w.
6
Comprehensive fitness landscape of SARS-CoV-2 M reveals insights into viral resistance mechanisms.SARS-CoV-2 M 的综合适应景观揭示了病毒耐药机制的见解。
Elife. 2022 Jun 20;11:e77433. doi: 10.7554/eLife.77433.
7
Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro.基于 SARS-CoV-2 3CLpro 催化结构域的 X 射线晶体结构对人冠状病毒 3CLpro 二聚倾向的研究。
Int J Mol Sci. 2022 May 9;23(9):5268. doi: 10.3390/ijms23095268.
8
A new inactive conformation of SARS-CoV-2 main protease.严重急性呼吸综合征冠状病毒2型主要蛋白酶的一种新的无活性构象。
Acta Crystallogr D Struct Biol. 2022 Mar 1;78(Pt 3):363-378. doi: 10.1107/S2059798322000948. Epub 2022 Feb 21.
9
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor.通过过渡态类似物抑制剂调节 SARS-CoV-2 主蛋白酶的单体-二聚体平衡和催化活性。
Commun Biol. 2022 Mar 1;5(1):160. doi: 10.1038/s42003-022-03084-7.
10
SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.SARS-CoV-2 模拟进入 exascale 时代,以预测整个蛋白质组中显著的刺突开口和隐蔽口袋。
Nat Chem. 2021 Jul;13(7):651-659. doi: 10.1038/s41557-021-00707-0. Epub 2021 May 24.